14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Dec 04, 2019 $49.05 $49.13 $48.14 $48.87 595 680
Dec 03, 2019 $49.54 $49.80 $48.52 $48.84 684 191
Dec 02, 2019 $49.22 $49.88 $48.49 $49.60 1 116 012
Nov 29, 2019 $48.00 $49.35 $47.82 $48.96 371 411
Nov 27, 2019 $48.18 $48.49 $47.65 $48.45 328 840
Nov 26, 2019 $47.10 $48.58 $46.66 $47.98 537 924
Nov 25, 2019 $44.76 $47.29 $44.62 $47.08 451 238
Nov 22, 2019 $43.82 $44.68 $43.36 $44.37 327 803
Nov 21, 2019 $43.69 $43.90 $42.66 $43.61 196 836
Nov 20, 2019 $43.02 $44.03 $42.54 $43.38 605 608
Nov 19, 2019 $42.76 $44.35 $42.76 $43.19 397 230
Nov 18, 2019 $40.91 $42.56 $40.52 $42.49 526 369
Nov 15, 2019 $43.33 $43.33 $40.78 $40.97 507 274
Nov 14, 2019 $44.32 $44.64 $42.83 $42.99 290 666
Nov 13, 2019 $44.49 $45.47 $44.06 $44.64 226 085
Nov 12, 2019 $44.34 $46.39 $44.34 $44.86 225 688
Nov 11, 2019 $43.78 $45.45 $43.15 $44.57 399 075
Nov 08, 2019 $40.56 $43.68 $40.36 $43.28 707 403
Nov 07, 2019 $40.70 $41.25 $40.15 $40.61 436 522
Nov 06, 2019 $44.10 $46.16 $40.16 $40.27 990 515
Nov 05, 2019 $47.18 $47.80 $46.78 $47.62 299 693
Nov 04, 2019 $47.08 $47.18 $46.34 $47.00 264 460
Nov 01, 2019 $44.98 $46.54 $44.82 $46.32 297 947
Oct 31, 2019 $44.00 $44.97 $43.30 $44.87 301 087
Oct 30, 2019 $43.64 $44.44 $43.56 $44.40 121 704
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT